Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O) — Stella

Home/Cancer T1-N0 or T2-N0 of the Oral Cavity/Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)

View on ClinicalTrials.gov

Recruiting

Back to Cancer T1-N0 or T2-N0 of the Oral Cavity trials

Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Gui de Chauliac Hospital, ENT Department 80 rue Augustin Fliche, Montpellier, Hérault

Key details

Sponsor

University Hospital, Montpellier

Enrollment target

~25 participants

Started

May 2018

Primary completion

July 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.